Clinical Trial Update: The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms [NA]

View source ↗

Summary

Clinical trial update on the p48/64 MW HPC Flow Modulation Device for wide-neck intracranial aneurysms; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fusiform Aneurysm
• Hemorrhagic Stroke
• Intracranial Aneurysm
• Saccular Aneurysm

Drugs mentioned

• p48/64 MW HPC Flow Modulation Device

Snippet

Sponsor: phenox Inc. | Conditions: Hemorrhagic Stroke, Aneurysm, Intracranial | NA | Status: RECRUITING